The metabolic syndrome in women

被引:23
作者
Rosano, Giuseppe M. C. [1 ]
Vitale, Cristiana [1 ]
Mercuro, Giuseppe [2 ]
机构
[1] IRCCS San Raffaele Hosp, Dept Internal Med, Ctr Clin & Basic Res, Via Pisana 235, I-00163 Rome, Italy
[2] Univ Cagliari, Dept Cardiol, Cagliari, Italy
关键词
cardiovascular risk; estradiol; hormone replacement therapy; menopause; prognosis; therapy;
D O I
10.2217/17455057.2.6.889
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
The clustering of metabolic risk factors, overweight and hypertension is of particular importance in postmenopausal women due to the negative effect of menopause on bodyweight, glucose metabolism and the development of hypertension. Menopause acts directly as a risk factor by reducing the direct beneficial effect of ovarian hormones on cardiovascular functions, and indirectly by negatively influencing traditional risk factors for coronary artery disease. All changes occurring after the menopause must be regarded under a unifying mechanism that induces unfavorable changes in cardiovascular risk factors and vascular functions, which interact with each other, amplifying the effect of ovarian hormone deficiency and aging.
引用
收藏
页码:889 / 898
页数:10
相关论文
共 56 条
[1]
Strategies to prevent type 2 diabetes [J].
Abuissa, H ;
Bell, DSH ;
O'Keefe, JH .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) :1107-1114
[2]
Norethindrone acetate enhances the antiatherogenic effect of 17β-estradiol -: A secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits [J].
Alexandersen, P ;
Haarbo, J ;
Sandholdt, I ;
Shalmi, M ;
Lawaetz, H ;
Christiansen, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (06) :902-907
[3]
THE IMPORTANCE OF TRIGLYCERIDES - RESULTS FROM THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY [J].
ASSMANN, G ;
SCHULTE, H .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 :99-103
[4]
Avogaro P, 1965, Epatologia, V11, P226
[5]
Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy [J].
Bruschi, F ;
Meschia, M ;
Soma, M ;
Perotti, D ;
Paoletti, R ;
Crosignani, PG .
OBSTETRICS AND GYNECOLOGY, 1996, 88 (06) :950-954
[6]
Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome [J].
Carr, DB ;
Utzschneider, KM ;
Hull, RL ;
Kodama, K ;
Retzlaff, BM ;
Brunzell, JD ;
Shofer, JB ;
Fish, BE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2004, 53 (08) :2087-2094
[8]
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women [J].
Chmouliovsky, L ;
Habicht, F ;
James, RW ;
Lehmann, T ;
Campana, A ;
Golay, A .
MATURITAS, 1999, 32 (03) :147-153
[10]
Cifkova R, 2003, J Hypertens, V21, P1779